161 related articles for article (PubMed ID: 15922838)
1. Cytotoxic activity of new lanthanum (III) complexes of bis-coumarins.
Kostova I; Momekov G; Zaharieva M; Karaivanova M
Eur J Med Chem; 2005 Jun; 40(6):542-51. PubMed ID: 15922838
[TBL] [Abstract][Full Text] [Related]
2. Synthesis, characterization and cytotoxicity of lanthanum(III) complexes with novel 1,10-phenanthroline-2,9-bis-alpha-amino acid conjugates.
Wang ZM; Lin HK; Zhu SR; Liu TF; Zhou ZF; Chen YT
Anticancer Drug Des; 2000 Dec; 15(6):405-11. PubMed ID: 11716433
[TBL] [Abstract][Full Text] [Related]
3. Synthesis, physicochemical characterization, and cytotoxic screening of new zirconium complexes with coumarin derivatives.
Kostova I; Manolov I; Karaivanova M
Arch Pharm (Weinheim); 2001 May; 334(5):157-62. PubMed ID: 11413821
[TBL] [Abstract][Full Text] [Related]
4. Effects of multidrug resistance (MDR1) P-glycoprotein expression levels and coordination metal on the cytotoxic potency of multidentate (N4O2) (ethylenediamine)bis[propyl(R-benzylimino)]metal(III) cations.
Sharma V; Crankshaw CL; Piwnica-Worms D
J Med Chem; 1996 Aug; 39(18):3483-90. PubMed ID: 8784446
[TBL] [Abstract][Full Text] [Related]
5. Bis(4,7-dimethyl-1,10-phenanthroline) sulfatooxovanadium(IV) as a novel apoptosis-inducing anticancer agent.
Narla RK; Dong Y; D'Cruz OJ; Navara C; Uckun FM
Clin Cancer Res; 2000 Apr; 6(4):1546-56. PubMed ID: 10778988
[TBL] [Abstract][Full Text] [Related]
6. Potential antitumor agents. 23.(1) Cytotoxic and differentiating activity of compounds related to hexamethylenebisacetamide.
Andreani A; Rambaldi M; Locatelli A; Andreani F; Lollini PL; Nanni P; Bossa R; Galatulas I
Farmaco; 1993 Nov; 48(11):1503-13. PubMed ID: 8110363
[TBL] [Abstract][Full Text] [Related]
7. Cytotoxic activity of cerium complexes with coumarin derivatives. Molecular modeling of the ligands.
Manolov I; Kostova I; Netzeva T; Konstantinov S; Karaivanova M
Arch Pharm (Weinheim); 2000 Apr; 333(4):93-8. PubMed ID: 10816901
[TBL] [Abstract][Full Text] [Related]
8. Cytotoxic effects of gold(III) complexes on established human tumor cell lines sensitive and resistant to cisplatin.
Calamai P; Carotti S; Guerri A; Mazzei T; Messori L; Mini E; Orioli P; Speroni GP
Anticancer Drug Des; 1998 Jan; 13(1):67-80. PubMed ID: 9474243
[TBL] [Abstract][Full Text] [Related]
9. Chelating agents as potential antitumorals: alpha-(N)-heterocyclic hydrazones and bis-alpha-(N)-heterocyclic hydrazones.
Savini L; Massarelli P; Chiasserini L; Nencini C; Pellerano C
Farmaco; 1997 Oct; 52(10):609-13. PubMed ID: 9507672
[TBL] [Abstract][Full Text] [Related]
10. Structure-cytotoxic activity relationships of simple hydroxylated coumarins.
Kawase M; Sakagami H; Hashimoto K; Tani S; Hauer H; Chatterjee SS
Anticancer Res; 2003; 23(4):3243-6. PubMed ID: 12926059
[TBL] [Abstract][Full Text] [Related]
11. Biological activity of 6,12-dihydro-1-benzopyrano[3,4-b][1,4]benzothiazin-6-ones.
Shah A; Naliapara Y; Sureja D; Motohashi N; Kurihara T; Kawase M; Satoh K; Sakagami H; Molnár J
Anticancer Res; 1998; 18(1A):61-3. PubMed ID: 9568056
[TBL] [Abstract][Full Text] [Related]
12. Study on some biologically active coordination compounds of metal ions (I)--Synthesis, characterization, structure and antitumor activity of complex of 3,6-di-(dimethylamino)-dibenzopyriodonium lanthanum EDTA.
Chen SY; Wang CH; Li D; Wang X
Sci China B; 1989 Aug; 32(8):918-26. PubMed ID: 2610865
[TBL] [Abstract][Full Text] [Related]
13. Synthesis and evaluation of anticancer activity of some imidazothiazolyl, imidazobenzothiazolyl and dihydroimidazothiazolyl coumarins.
Srimanth K; Rao VR; Krishna DR
Arzneimittelforschung; 2002; 52(5):388-92. PubMed ID: 12087925
[TBL] [Abstract][Full Text] [Related]
14. Organomercury (II) complexes with anti-carcinogenic agents. I. Synthesis and characterization.
Kaur J; Marwaha SS; Sodhi GS
Neoplasma; 1995; 42(4):187-90. PubMed ID: 7659184
[TBL] [Abstract][Full Text] [Related]
15. Interaction of La (III) and Tb (III) ions with purine nucleotides: evidence for metal chelation (N-7-M-PO3) and the effect of macrochelate formation on the nucleotide sugar conformation.
Tajmir-Riahi HA
Biopolymers; 1991 Aug; 31(9):1065-75. PubMed ID: 1664746
[TBL] [Abstract][Full Text] [Related]
16. Synthesis and tumor inhibiting activity of lanthanum (III) complexes with some 1-aminocycloalkancarboxylic acids.
Kovachev TB; Ivanov DS; Buyukliev RT; Konstantinov SM; Karaivanova MC
Pharmazie; 1996 Jan; 51(1):25-7. PubMed ID: 8999429
[TBL] [Abstract][Full Text] [Related]
17. Cytotoxic activity against a series of tumour cell lines of dimethyltin dichloride complexes with various donor ligands.
al-Allaf TA; Khuzaie RF; Rashan LJ; Halaseh WF
Boll Chim Farm; 1999 Jun; 138(6):267-71. PubMed ID: 10464976
[TBL] [Abstract][Full Text] [Related]
18. Novel pyrone side tetracyclic psoralen derivatives: synthesis and photobiological evaluation.
Dalla Via L; Uriarte E; Quezada E; Dolmella A; Ferlin MG; Gia O
J Med Chem; 2003 Aug; 46(18):3800-10. PubMed ID: 12930143
[TBL] [Abstract][Full Text] [Related]
19. Gold(III) complexes as a new family of cytotoxic and antitumor agents.
Marcon G; Messori L; Orioli P
Expert Rev Anticancer Ther; 2002 Jun; 2(3):337-46. PubMed ID: 12113057
[TBL] [Abstract][Full Text] [Related]
20. Cytotoxic activity of benzothiepins against human oral tumor cell lines.
Sugita Y; Hosoya H; Terasawa K; Yokoe I; Fujisawa S; Sakagami H
Anticancer Res; 2001; 21(4A):2629-32. PubMed ID: 11724331
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
